Anti-Obesity Drugs a Hot Topic in the Biotech Industry - MarketWatch (press release)

Posted by admin / Under Anti Obesity Medication

Anti-Obesity Drugs a Hot Topic in the Biotech Industry
MarketWatch (press release)
NEW YORK, NY, May 14, 2012 (MARKETWIRE via COMTEX) -- Biotech companies are looking to cash in on the anti-obesity drug market. The race to bring the first weight-loss pill to the market is heating up as Arena Pharmaceuticals weight-loss pill ...

and more »

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

Vivus Will Plummet If Qnexa Fails - Seeking Alpha

Posted by admin / Under Anti Obesity Medication


AFP
Vivus Will Plummet If Qnexa Fails
Seeking Alpha
As with all prior (or lack thereof) approvals for anti-obesity medications, Vivus faces the same challenges as many other companies focusing on this space. Qnexa, is a combination of phentermine, (the "beneficial" part of now extinct fen-phen) and ...
FDA Panel Gives Nod to New Diet Drug MedPage Today
New Weight-Loss Drug Shows Promise in Trial U.S. News & World Report

all 653 news articles »

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

Something better than orlistat in preventing obesity or weight gain - Food Consumer

Posted by admin / Under Anti Obesity Medication

Something better than orlistat in preventing obesity or weight gain
Food Consumer
By David Liu PHD Thursday April 26, 2012 (foodconsumer.org) -- Many people already know that there is an antiobesity medication called orlistat. This medication, indicated to treat obesity, prevents weight gain by interfering with fat absorption.

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

How the FDA Stifles New Cures, Part III: A Proposal for Reform - Forbes

Posted by admin / Under Anti Obesity Medication

How the FDA Stifles New Cures, Part III: A Proposal for Reform
Forbes
Today, GLP-1 analogues achieve nearly $2 billion in annual sales per drug, and analysts project similar sales for approved antiobesity drugs. Using those figures, we modeled the impact of an FDA policy that offered conditional approval to such ...

and more »

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

How the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are ... - Forbes

Posted by admin / Under Anti Obesity Medication


Forbes
How the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are ...
Forbes
Arena wasn't the only obesity-drug company to be blocked after promising trial results. Days after rejecting Lorqess, the agency (which has not approved any weight-control drugs in over a decade) turned back another antiobesity drug, ...

and more »

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

Pattaya Soi 6 Closed 400 Sex Workers Drug Tested - Pattaya Daily News

Posted by admin / Under Anti Obesity Medication


Pattaya Daily News
Pattaya Soi 6 Closed 400 Sex Workers Drug Tested
Pattaya Daily News
Most of the suspects said they had not taken illegal drugs. They blamed it antipyretic medicine or anti-obesity medication. The officers didn't buy that. However, the all urine samples were sent to Banglamung hospital for further laboratory tests.

and more »

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

Arna Pharmaceutical's Recent Spike Offers Income Opportunity - Seeking Alpha

Posted by admin / Under Anti Obesity Medication

Arna Pharmaceutical's Recent Spike Offers Income Opportunity
Seeking Alpha
Another company with a recent weight loss approval drug--Vivus(VVUS)-- pioneered the same path Arena just took. The FDA advisory committee endorsed the anti-obesity drug Qnexa in the last week of February 2012.The committee voted 20 to 2 to recommend ...

and more »

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

Arna Pharmaceutical's Recent Spike Offers Income Opportunity - Seeking Alpha

Posted by admin / Under Anti Obesity Medication


InPharm
Arna Pharmaceutical's Recent Spike Offers Income Opportunity
Seeking Alpha
Another company with a recent weight loss approval drug--Vivus(VVUS)-- pioneered the same path Arna just took. The FDA advisory committee endorsed the anti-obesity drug Qnexa in the last week of February 2012.The committee voted 20 to 2 to recommend ...
Obesity drugs vie for approval as FDA panel backs lorcaserin InPharm
Obesity: The next investment driver MSN Money

all 52 news articles »

Published on Monday 21st of May 2012 06:13:04 AM

continue reading

Our Services

Do not forget to check the lastest products and auctions related to Anti Obesity Medication as well as our free videos and podcasts.

best Anti Obesity Medication products current Anti Obesity Medication auctions current Anti Obesity Medication videos listen to Anti Obesity Medication podcasts

This Day In History